Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Capital Employed: 2020-2025

Historic Return on Capital Employed for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to 0.24%.

  • Harmony Biosciences Holdings' Return on Capital Employed changed negligibly% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 0.26% for FY2024, which is 7.00% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Return on Capital Employed stood at 0.24%, which was down 1.90% from 0.25% recorded in Q2 2025.
  • Harmony Biosciences Holdings' Return on Capital Employed's 5-year high stood at 0.30% during Q4 2023, with a 5-year trough of 0.11% in Q1 2021.
  • Over the past 3 years, Harmony Biosciences Holdings' median Return on Capital Employed value was 0.24% (recorded in 2024), while the average stood at 0.26%.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Return on Capital Employed climbed by 18bps in 2021, and later dropped by 7bps in 2025.
  • Harmony Biosciences Holdings' Return on Capital Employed (Quarterly) stood at 0.24% in 2021, then fell by 4bps to 0.21% in 2022, then increased by 10bps to 0.30% in 2023, then fell by 6bps to 0.24% in 2024, then remained steady at 0.24% in 2025.
  • Its last three reported values are 0.24% in Q3 2025, 0.25% for Q2 2025, and 0.23% during Q1 2025.